We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $120M
1-Year Est. Return 37.12%
This Fund
S&P 500
This Quarter Est. Return
+38.21%
1 Year Est. Return
+37.12%
3 Year Est. Return
+141.34%
5 Year Est. Return
+139.46%
10 Year Est. Return
AUM
$108M
AUM Growth
Cap. Flow
+$94.4M
Cap. Flow %
87.56%
Top 10 Hldgs %
39.31%
Holding
80
New
80
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 36.62%
2 Technology 17.3%
3 Financials 11.58%
4 Consumer Discretionary 8.7%
5 Energy 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTPI
76
DELISTED
Petros Pharmaceuticals
PTPI
$198K 0.18%
+180
New +$169K
LTRN icon
77
Lantern Pharma
LTRN
$36.6M
$193K 0.18%
+10,000
New +$173K
CASY icon
78
Casey's General Stores
CASY
$31.8B
$179K 0.17%
+1,000
New +$181K
HII icon
79
Huntington Ingalls Industries
HII
$10.6B
$170K 0.16%
+1,000
New +$159K
EOLS icon
80
Evolus
EOLS
$377M
$157K 0.15%
+46,620
New +$175K

Similar funds

CM Management's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for CM Management, which disclosed 80 positions worth $108M. Its ten largest holdings account for 39% of the portfolio.

Its largest position is Cytokinetics: 325,000 shares worth $6.75M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, followed by Technology and Financials.

  • CM Management's largest Q4 2020 buy was Cytokinetics: 325,000 shares worth $6.75M.
  • CM Management's ten largest holdings make up 39% of its $108M portfolio in Q4 2020.
  • CM Management disclosed 80 positions in Q4 2020, its first 13F filing on record.

Based on CM Management's 13F filing for Q4 2020, filed 4 Feb 2021.